@Capt3958@julie_justo@pharmgirlsarah@DrBiochemistry@BBookstaver_USC@ae_gross If organized properly, pharmacists can administer tests to patients in their cars, protecting other consumers. Because of their accessibility, pharmacists should become key stakeholders in the push for more tests as well as in the delivery of timely and accurate results.
Super proud to be an author in @NEJM! Treatment of HTN in those with COPD should be considered a priority. Think of COPD as another compelling indication for treatment.
So proud of Drs. Shannon Finks and Timothy Self for their recent publication in NEJM!!!!! @UTPharmacy @uthsc @ACCP @ASHPOfficial https://t.co/bJB2fJABV5
@wbaker0621@accpcardprn@NEJM Thanks all! Super proud to be included as author in @NEJM! Would like to argue for COPD to be included as a compelling indication in the next HTN guidelines!
@CardiacRX@NEJM Thank you @CardiacRX. I’m definitely on a professional high, no pharmaceuticals needed. It is an honor to be included as an author in @NEJM and am hopeful that control of HTN in patients with COPD will be considered a priority and control rates will be positively impacted.
@accpcardprn I think age is relative. Some of my patients at 65 are “older” functionally than some 85 year olds I see. I like the arguement that we should look at a frailty index to help guide decisions. Gait speed was included in SPRINT as a part of frailty assessment.
@accpcardprn I believe my elderly patients will benefit from a lower BP target of 130 mm Hg. But, I prioritize safety factors before adding on therapy to an elders medication profile. The factors I consider are much related to the SPRINT inclusion criteria.